Navigation Links
Amgen Presents Data From First Nplate(R) Study in Children With Chronic ITP
Date:12/7/2009

NEW ORLEANS, Dec. 7 /PRNewswire-FirstCall/ -- Amgen Inc. (Nasdaq: AMGN) today announced results from its first Phase 1/2 study evaluating the safety and efficacy of Nplate® (romiplostim) in children with chronic immune thrombocytopenic purpura (ITP). Chronic ITP is a serious autoimmune disorder characterized by low platelet counts in the blood (thrombocytopenia), which can lead to serious bleeding events. The data were presented as an oral presentation at the 2009 American Society of Hematology (ASH) Annual Meeting and Exposition (ASH Abstract #680). Additionally, updated five-year follow-up results from an ongoing, open-label extension study in adults were presented and add to the data available on the long-term efficacy and safety of Nplate in adult patients with chronic ITP (ASH Abstract #681).

Results from Phase 1/2 Study in Children (Abstract #680)

ITP in children most commonly presents as an acute illness; however, 20-30 percent of these cases will persist as chronic ITP (duration over six months). Results of the study showed that treatment with Nplate appeared to be generally well-tolerated compared to placebo in children (aged 12 months to less than 18 years old) with chronic ITP (treatment related adverse events = 18 percent vs. 20 percent, respectively).

"Currently, most drug treatment options for children with chronic ITP involve immunosuppression," said Dr. George R. Buchanan, professor of Pediatrics at the University of Texas Southwestern Medical Center at Dallas. "This is the first study of an agent that stimulates platelet production in the pediatric population. The results suggest that Nplate could potentially be an important treatment option for selected children suffering from chronic ITP."

Safety results of the study showed that adverse event rates were similar between
'/>"/>

SOURCE Amgen
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amgen Board Authorizes $5 Billion Increase in Stock Repurchase Program
2. New Amgen Scholars Web site Launches to Build a Global Network for Future Scientists
3. Amgen Highlights Data to be Presented at ASH
4. Amgen Recognized for Best Pipeline and Best New Drug at Scrip Awards
5. Amgen Announces Overall Survival Results for Vectibix(R) in First-Line Metastatic Colorectal Cancer
6. Call for Applications: The Amgen Award for Science Teaching Excellence
7. Amgen Highlights Data to be Presented at American Society for Bone and Mineral Research (ASBMR) Meeting
8. Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes
9. Amgen Issues Statement on Outcomes of Advisory Committee for Reproductive Health Drugs (ACRHD) Meeting
10. Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)
11. CDC Foundation Partners with Amgen, CDC to Reduce Infections Among Cancer Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... -- Henry Schein, Inc. (NASDAQ: HSIC ), the world,s ... dental, animal health and medical practitioners, announced today that the ... , September 4, 2014 – Baird 2014 Healthcare Conference ... ET , September 8, 2014 – Morgan ... , NY at 1:25 p.m. ET Henry Schein,s ...
(Date:8/21/2014)... PARK, N.J. , Aug. 21, 2014 /PRNewswire/ ... pharmacy group purchasing organization (GPO), is pleased to ... to collaborate on a host of innovative specialty ... help Aurora deliver enhanced therapy management services to ... Management (OTM) system. Aurora will use ...
(Date:8/21/2014)... WOONSOCKET, R.I. , Aug. 21, 2014 CVS ... early tender results, applicable Reference Yields and consideration payable in ... Offers") commenced on August 7, 2014 for (1) any and ... and All Notes") and (2) up to a maximum amount ... due 2041 and 5.750% Senior Notes due 2017 (collectively, the ...
Breaking Medicine Technology:Henry Schein To Present At Two Investor Conferences In September 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 2Aurora Health Care Partners with Armada Health Care to Deliver Added Pharmacy Capabilities to Specialty Patients 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 2CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 3CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 4CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 5CVS Caremark Corporation Announces Early Results of Tender Offers, Pricing, Election of Early Settlement and Increase in the Maximum Tender Offer Amount 6
... Ill., Nov. 8, 2010 ... ... --> ... var first_result; // Results are keyed by longUrl, so we need to grab the first one. for (var r ...
... 8, 2010 Reportlinker.com announces that a ... its catalogue: The Future ... leading companies, and opportunities for target expansion ... G-Protein-coupled receptors (GPCRs) constitute the largest ...
Cached Medicine Technology:Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 2Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 3Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 4Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 5Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 6Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 7Abbott Joins Clinton Health Access Initiative in Effort to Improve Infant Testing for HIV in Africa 8The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion 2The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion 3The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion 4The Future of GPCRs in Drug Discovery: Novel Technologies, Leading Companies, and Opportunities for Target Expansion 5
(Date:8/21/2014)... Stevin McNamara’s original approach to guitar music is ... music that has existed in India for centuries. Literally meaning ... scale or some fixed sequence of notes, but is considered ... appropriate time of day or season of the year — ... musician occurs, in its turn creating an unique “sound manifestation” ...
(Date:8/21/2014)... Dotinga HealthDay Reporter THURSDAY, ... achieving orgasms during sex with a regular partner, straight ... study suggests. Using surveys of single people, the Kinsey ... climax about 85 percent of the time during sex, while ... females placed third, achieving orgasm during about 63 percent of ...
(Date:8/21/2014)... HealthDay Reporter THURSDAY, Aug. ... in treating respiratory syncytial virus (RSV), a leading cause of ... major progress in being able to treat human RSV infections ... second only to influenza virus," said study author Dr. John ... College of Medicine in Memphis. "There is no ...
(Date:8/21/2014)... The International and American Associations for Dental Research (IADR/AADR) ... Prevalence Following Five Decades of Decline." This study, by ... Chapel Hill, USA, follows edentulism (tooth loss) over the ... losing teeth and requiring dentures. It is published in ... Dental Research ( JDR ). , The ...
(Date:8/21/2014)... According to the new report “Waterborne Coatings ... PTFE, PVDF, PVDC, & Others), by Application (Architectural, ... & Others) - Global Forecast to 2019” published ... estimated to reach $77,838.71 Million by 2019. , ... spread through 225 Slides and in-depth TOC on ...
Breaking Medicine News(10 mins):Health News:Raga Cycle of Shakti Guitar Follows The Sun 2Health News:Raga Cycle of Shakti Guitar Follows The Sun 3Health News:Study: Men, Lesbians More Likely to Have Orgasms 2Health News:Study: Men, Lesbians More Likely to Have Orgasms 3Health News:New Drug May Fight Serious Respiratory Virus in Infants 2Health News:New Drug May Fight Serious Respiratory Virus in Infants 3Health News:Study shows steep decline in tooth loss, increase in socioeconomic disparities 2Health News:Waterborne Coatings Market worth $77,838.71 Million by 2019 – New Report by MarketsandMarkets 2Health News:Waterborne Coatings Market worth $77,838.71 Million by 2019 – New Report by MarketsandMarkets 3Health News:Waterborne Coatings Market worth $77,838.71 Million by 2019 – New Report by MarketsandMarkets 4
... Hospital investigators have identified childhood cancer survivors who ... in part due to the lifesaving bone marrow ... underscore the need for long-term monitoring and early ... additional health education, researchers said. Among the measures ...
... of a screening urine dipstick to diagnose chronic kidney ... confirm Penn State College of Medicine researchers, who validated ... urine dipsticks have routinely been performed on healthy children ... Sekhar, M.D., assistant professor of pediatrics. "The AAP made ...
... of arthritis is greater for African Americans and Hispanics, ... Centers for Disease Control and Prevention (CDC) report published ... . According to the Arthritis Foundation, these findings suggest ... strategies aimed at arthritis prevention and management, particularly among ...
... ... Zoernack and the Socially Responsible (SRI) Bullion Fund Deploy Equity Long/Short Strategy ... by buying companies with good bottom up fundamentals and sell closely related ... minimizing correlation to the overall markets. In this case, we go long ...
... ... Conference, taking place in Houston, TX April 19, 20 and 21, 2010. Interaction ... Practices" and Best Practices in Learning and Development at Kaiser Permanente. , ... Cambridge, MA (PRWEB) April ...
... , ... launched its BodyTrace eScale and Website to the market. The world,s first GSM-enabled bathroom scale ... company,s web-scale and website represents a new milestone in Health 2.0 to promote the collaboration ... ...
Cached Medicine News:Health News:Research findings underscore needed action to safeguard lungs of young cancer survivors 2Health News:Research findings underscore needed action to safeguard lungs of young cancer survivors 3Health News:Routine screening for pediatric chronic kidney disease is not effective 2Health News:Minorities hit hardest by arthritis 2Health News:Steven Zoernack and The Bullion Fund Deploy Equity Long/Short Strategy with Apple (AAPL) and Research in Motion (RIMM) 2Health News:Steven Zoernack and The Bullion Fund Deploy Equity Long/Short Strategy with Apple (AAPL) and Research in Motion (RIMM) 3Health News:Steven Zoernack and The Bullion Fund Deploy Equity Long/Short Strategy with Apple (AAPL) and Research in Motion (RIMM) 4Health News:Steven Zoernack and The Bullion Fund Deploy Equity Long/Short Strategy with Apple (AAPL) and Research in Motion (RIMM) 5Health News:Steven Zoernack and The Bullion Fund Deploy Equity Long/Short Strategy with Apple (AAPL) and Research in Motion (RIMM) 6Health News:Interaction Associates to Sponsor HCI Talent Management for Health Care Conference 2Health News:Interaction Associates to Sponsor HCI Talent Management for Health Care Conference 3Health News:World's First GSM-Enabled Scale Gets Set for Launch to Help in Weight Loss 2
For the quantitative determination of Glycohemoglobin in blood....
For the quantitative determination of Glycohemoglobin (HbA1) in blood by,cation exchange resin. The test is to be used to monitor long-term glucose,control in diabetes mellitus....
... storage protein for iron. The ferritin molecule ... of heavy and light subunits, which surrounds ... phosphate [1]. Ferritin is synthesized in the ... with major concentrations found in the liver, ...
Rapid turn-around time, results in less than 4 hours...
Medicine Products: